[ Price : $8.95]
AbbVie files a supplemental NDA seeking approval for a new, fixed-duration, all-oral combination regimen of Venclexta (venetoclax)...[ Price : $8.95]
FDA says its Arthritis Advisory Committee is no longer worth the effort and expense needed to maintain it, and it has been termina...[ Price : $8.95]
FDA commissioner Martin Makary says he wants to find ways to get drugs to consumers faster, but also find ways to reduce the need ...[ Price : $8.95]
Newly appointed CBER director Vinay Prasad abruptly leaves the agency after being attacked by Trump influencer Laura Loomer for ex...[ Price : $8.95]
FDA grants Calidi Biotherapeutics fast-track status for CLD-201, an allogeneic stem-cell-loaded oncolytic virus being developed to...[ Price : $8.95]
Johnson & Johnson files a supplemental BLA seeking to update the prescribing information for Tremfya (guselkumab) to include new d...[ Price : $8.95]
FDA recommends placing 7-hydroxymitragynine (7-OH) a highly concentrated, synthetic byproduct of the kratom plant under the Contr...[ Price : $8.95]
FDA warns Indias Shiva Analyticals Private Limited about CGMP violations in its work as a contract testing laboratory.